Tag:
Biovitrum
Latest Headlines
Latest Headlines
Biovitrum merges with Swedish Orphan in $493M deal
Sweden's Biovitrum has snapped up Swedish Orphan in a $493 million deal. The merger will create Swedish Orphan Biovitrum, marrying Orphan's business and marketing savvy with Biovitrum's development
Biovitrum to spin out small molecule subsidiary
Sweden's Biovitrum announced that it will spin out its small molecule subsidiary Cambridge Biotechnology (CBT). CBT's pipeline includes one Phase II neuropathic pain project; Phase II and Phase I
Symphogen inks $330M collaboration pact with Genentech
Denmark's Symphogen has inked a $330 million collaboration deal with Genentech to discover new antibodies for three infectious disease
Biovitrum AB cuts staff as it restructures R&D ops
Sweden's Biovitrum AB has restructured its R&D operations, winnowing out about 100 people either through layoffs or by reassigning them to other work. Biovitrum says it will focus on specialist
